CDC7 as a novel biomarker and druggable target in cancer
Authors:
- 3 June 2022
- journal article
- review article
- Published by Springer Nature in Clinical and Translational Oncology
- Vol. 24 (10) , 1856-1864
Abstract
Due to the bottlenecks encountered in traditional treatment for tumor, more effective drug targets need to be developed. Cell division cycle 7 kinase plays an important role in DNA replication, DNA repair and recombination signaling pathways. In this review, we first describe recent studies on the role of CDC7 in DNA replication in normal human tissues, and then we integrate new evidence focusing on the important role of CDC7 in replication stress tolerance of tumor cells and its impact on the prognosis of clinical oncology patients. Finally, we comb through the CDC7 inhibitors identified in recent studies as a reference for further research in clinical practice.Keywords
Funding Information
- the National Nature Science Foundation of China (No. 82072340)
- Scientific and Technological Innovation Major Base of Guangxi (2018-15-Z04)
- State Project for Essential Drug Research and Development (2019ZX09301132)
- Guangxi Key Research and Development Project (AB20117001)
This publication has 69 references indexed in Scilit:
- Replication stress and cancerNature Reviews Cancer, 2015
- The Potent Cdc7-Dbf4 (DDK) Kinase Inhibitor XL413 Has Limited Activity in Many Cancer Cell Lines and Discovery of Potential New DDK Inhibitor ScaffoldsPLOS ONE, 2014
- Regulation and roles of Cdc7 kinase under replication stressCell Cycle, 2014
- DNA Replication and Oncogene-Induced Replicative StressCurrent Biology, 2014
- SAR and in vivo evaluation of 4-aryl-2-aminoalkylpyrimidines as potent and selective Janus kinase 2 (JAK2) inhibitorsBioorganic & Medicinal Chemistry Letters, 2012
- Discovery of XL413, a potent and selective CDC7 inhibitorBioorganic & Medicinal Chemistry Letters, 2012
- A Genome-wide Camptothecin Sensitivity Screen Identifies a Mammalian MMS22L-NFKBIL2 Complex Required for Genomic StabilityMolecular Cell, 2010
- The DNA Damage Response: Making It Safe to Play with KnivesMolecular Cell, 2010
- How do Cdc7 and cyclin-dependent kinases trigger the initiation of chromosome replication in eukaryotic cells?Genes & Development, 2010
- Drug design with Cdc7 kinase: a potential novel cancer therapy targetDrug Design, Development and Therapy, 2008